These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 29665376)
1. Insect cell-produced recombinant protein subunit vaccines protect against Zika virus infection. Qu P; Zhang W; Li D; Zhang C; Liu Q; Zhang X; Wang X; Dai W; Xu Y; Leng Q; Zhong J; Jin X; Huang Z Antiviral Res; 2018 Jun; 154():97-103. PubMed ID: 29665376 [TBL] [Abstract][Full Text] [Related]
2. Yeast-produced subunit protein vaccine elicits broadly neutralizing antibodies that protect mice against Zika virus lethal infection. Zhang W; Qu P; Li D; Zhang C; Liu Q; Zou G; Dupont-Rouzeyrol M; Lavillette D; Jin X; Yin F; Huang Z Antiviral Res; 2019 Oct; 170():104578. PubMed ID: 31394119 [TBL] [Abstract][Full Text] [Related]
3. Rational Design of Zika Virus Subunit Vaccine with Enhanced Efficacy. Tai W; Chen J; Zhao G; Geng Q; He L; Chen Y; Zhou Y; Li F; Du L J Virol; 2019 Sep; 93(17):. PubMed ID: 31189716 [TBL] [Abstract][Full Text] [Related]
4. Critical neutralizing fragment of Zika virus EDIII elicits cross-neutralization and protection against divergent Zika viruses. Tai W; He L; Wang Y; Sun S; Zhao G; Luo C; Li P; Zhao H; Fremont DH; Li F; Jiang S; Zhou Y; Du L Emerg Microbes Infect; 2018 Jan; 7(1):7. PubMed ID: 29362446 [TBL] [Abstract][Full Text] [Related]
5. Two immunogenic recombinant protein vaccine candidates showed disparate protective efficacy against Zika virus infection in rhesus macaques. Yang R; Liu Q; Pang W; Gao F; Liang H; Zhang W; Lin Y; Li M; Liu Z; Gao GF; Zhang L; Xiao H; Zheng Y; Huang Z; Jin X Vaccine; 2021 Feb; 39(6):915-925. PubMed ID: 33451779 [TBL] [Abstract][Full Text] [Related]
6. Immunization of Zika virus envelope protein domain III induces specific and neutralizing immune responses against Zika virus. Yang M; Dent M; Lai H; Sun H; Chen Q Vaccine; 2017 Jul; 35(33):4287-4294. PubMed ID: 28669618 [TBL] [Abstract][Full Text] [Related]
7. Dengue virus envelope protein domain III-elicited antibodies mediate cross-protection against Zika virus in a mouse model. Zhou Y; Chen D; Yang L; Zou W; Duan Z; Zhang Y; Wen J Virus Res; 2020 Mar; 278():197882. PubMed ID: 31981774 [TBL] [Abstract][Full Text] [Related]
8. A Recombinant Subunit Based Zika Virus Vaccine Is Efficacious in Non-human Primates. Medina LO; To A; Lieberman MM; Wong TAS; Namekar M; Nakano E; Andersen H; Yalley-Ogunro J; Greenhouse J; Higgs S; Huang YS; Vanlandingham DL; Horton JS; Clements DE; Lehrer AT Front Immunol; 2018; 9():2464. PubMed ID: 30467501 [TBL] [Abstract][Full Text] [Related]
9. Zika Virus-Like Particles Bearing a Covalent Dimer of Envelope Protein Protect Mice from Lethal Challenge. De Lorenzo G; Tandavanitj R; Doig J; Setthapramote C; Poggianella M; Sanchez-Velazquez R; Scales HE; Edgar JM; Kohl A; Brewer J; Burrone OR; Patel AH J Virol; 2020 Dec; 95(1):. PubMed ID: 33028720 [TBL] [Abstract][Full Text] [Related]
10. Immunization With a Novel Human Type 5 Adenovirus-Vectored Vaccine Expressing the Premembrane and Envelope Proteins of Zika Virus Provides Consistent and Sterilizing Protection in Multiple Immunocompetent and Immunocompromised Animal Models. Guo Q; Chan JF; Poon VK; Wu S; Chan CC; Hou L; Yip CC; Ren C; Cai JP; Zhao M; Zhang AJ; Song X; Chan KH; Wang B; Kok KH; Wen Y; Yuen KY; Chen W J Infect Dis; 2018 Jul; 218(3):365-377. PubMed ID: 29617816 [TBL] [Abstract][Full Text] [Related]
11. Japanese encephalitis virus E protein domain III immunization mediates cross-protection against Zika virus in mice via antibodies and CD8 Duan ZL; Zou WW; Chen D; Zhu JY; Wen JS Virus Res; 2024 Jul; 345():199376. PubMed ID: 38643856 [TBL] [Abstract][Full Text] [Related]
12. Role of Zika Virus Envelope Protein Domain III as a Target of Human Neutralizing Antibodies. Gallichotte EN; Young EF; Baric TJ; Yount BL; Metz SW; Begley MC; de Silva AM; Baric RS mBio; 2019 Sep; 10(5):. PubMed ID: 31530669 [TBL] [Abstract][Full Text] [Related]
13. Recombinant Chimpanzee Adenovirus Vaccine AdC7-M/E Protects against Zika Virus Infection and Testis Damage. Xu K; Song Y; Dai L; Zhang Y; Lu X; Xie Y; Zhang H; Cheng T; Wang Q; Huang Q; Bi Y; Liu WJ; Liu W; Li X; Qin C; Shi Y; Yan J; Zhou D; Gao GF J Virol; 2018 Mar; 92(6):. PubMed ID: 29298885 [TBL] [Abstract][Full Text] [Related]
14. Zika Virus Attenuation by Codon Pair Deoptimization Induces Sterilizing Immunity in Mouse Models. Li P; Ke X; Wang T; Tan Z; Luo D; Miao Y; Sun J; Zhang Y; Liu Y; Hu Q; Xu F; Wang H; Zheng Z J Virol; 2018 Sep; 92(17):. PubMed ID: 29925661 [TBL] [Abstract][Full Text] [Related]
15. Vaccine protection against Zika virus from Brazil. Larocca RA; Abbink P; Peron JP; Zanotto PM; Iampietro MJ; Badamchi-Zadeh A; Boyd M; Ng'ang'a D; Kirilova M; Nityanandam R; Mercado NB; Li Z; Moseley ET; Bricault CA; Borducchi EN; Giglio PB; Jetton D; Neubauer G; Nkolola JP; Maxfield LF; De La Barrera RA; Jarman RG; Eckels KH; Michael NL; Thomas SJ; Barouch DH Nature; 2016 Aug; 536(7617):474-8. PubMed ID: 27355570 [TBL] [Abstract][Full Text] [Related]
16. Maternal immunization with a DNA vaccine candidate elicits specific passive protection against post-natal Zika virus infection in immunocompetent BALB/c mice. Wang R; Liao X; Fan D; Wang L; Song J; Feng K; Li M; Wang P; Chen H; An J Vaccine; 2018 Jun; 36(24):3522-3532. PubMed ID: 29753607 [TBL] [Abstract][Full Text] [Related]
17. Addition of nucleotide adjuvants enhances the immunogenicity of a recombinant subunit vaccine against the Zika virus in BALB/c mice. Valdes I; Suzarte E; Lazo L; Cobas K; Cabrales A; Pérez Y; Garateix R; Silva JA; Aguilar JC; Guzman CA; Guillén G Vaccine; 2024 Nov; 42(25):126213. PubMed ID: 39138071 [TBL] [Abstract][Full Text] [Related]
19. Immunization with truncated envelope protein of Zika virus induces protective immune response in mice. Han JF; Qiu Y; Yu JY; Wang HJ; Deng YQ; Li XF; Zhao H; Sun HX; Qin CF Sci Rep; 2017 Aug; 7(1):10047. PubMed ID: 28855646 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic and vaccine potential of Zika virus envelope protein (E) derivates produced in bacterial and insect cells. Lunardelli VAS; Almeida BDS; Apostolico JS; Rezende T; Yamamoto MM; Pereira SS; Bueno MFC; Pereira LR; Carvalho KI; Slhessarenko RD; de Souza Ferreira LC; Boscardin SB; Rosa DS Front Immunol; 2023; 14():1071041. PubMed ID: 37006270 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]